Gilead files US marketing application for remdesivir
Gilead Sciences Inc said on Monday it has filed a marketing application with the U.S. Food and Drug Administration for its experimental COVID-19 drug remdesivir.
FDA opens investigation at California produce supplier as onion recall expands
The recall, issued by Thomson on Aug. 1, includes red, yellow, white and sweet yellow onions which were shipped beginning May 1 in cartons weighing between five and 50 pounds, and mesh sacks between two and 50 pounds.
Doctors, hospitals launch voter registration efforts as Election Day nears
Amid the dual public health crises of COVID-19 and racism, some in the medical community are prescribing a somewhat nontraditional remedy: voting. Hospitals, doctors and healthcare institutions across the country are committing to efforts to engage Americans in the election process as part of Civic Health Month.
Trump will require insurance companies to cover preexisting conditions
The president recently took action to lower the cost of prescription drugs.
India’s star yoga guru angers critics by selling COVID-19 ‘cure’
An Indian yoga televangelist, who is an ally of Prime Minister Narendra Modi, claims to have already found the cure for the new coronavirus -- and it's for sale.
Gilead Sciences plans on producing over 2M coronavirus treatment courses by end of 2020
Gilead Sciences said on Thursday that the drug company has gone into hyperdrive creating the antiviral drug remdesivir, the first treatment shown to be effective against COVID-19.
Bausch Health to spin off eye-care business
The eye-care unit, known as Bausch & Lomb, had $3.7 billion in revenue last year, compared with about $4.9 billion from the rest of the company.
State AGs letter urging availability of coronavirus drug shot down by HHS
Gilead will charge U.S. hospitals $3,120 for the average patient with commercial insurance.
J&J reaches $1B deal with US for COVID-19 vaccine, 100M experimental doses
The company's SARS-CoV-2 investigational vaccine, Ad26.COV2.S, will be provided at a "global not-for-profit basis for emergency pandemic use," the pharmaceutical giant said.
Moderna details coronavirus vaccine pricing as orders roll in
Moderna says orders for the experimental COVID vaccine are rolling in.
Clorox wipes shortage expected to continue until 2021 as coronavirus drives demand
Clorox, the world's biggest cleaning products maker, said grocery store shelves won’t be fully stocked with the company's disinfecting wipes until next year, according to a report on Tuesday.
U.S. pursues nearly $13 billion of claims in Purdue Pharma opioid probes, sources say
U.S. prosecutors are pursuing possible penalties of nearly $13 billion to resolve investigations of OxyContin maker Purdue Pharma.
Tiny Texas company is running most of the drive-thru coronavirus testing in US
After the U.S. government reportedly spent nearly $230 million to pay for COVID-19 test sites around the country, one small Texas company ended up establishing hundreds of testing stations, while bringing in more than $90 million in federal contracts.
Anti-abortion centers given coronavirus bailout of at least $4M: Report
Anti-abortion centers received at least $4 million in forgivable federal loans when the government issued its first coronavirus bailout, a report said Monday.
Lilly starts late-stage study of coronavirus drug in nursing homes
Lilly is already testing the drug in hospitals to study whether it can work as a treatment in patients who have the disease.
Siemens Healthineers to acquire cancer treatment company Varian for $16.4B
Under the agreed transaction, Siemens Healthineers will acquire all shares in Varian for $177.50 each in cash, representing a 24% premium to the U.S. company’s closing price on Friday.
Pharmacists push for law that will allow them to administer coronavirus tests
Wait times for coronavirus test results have come down since the pandemic began, but there are still 10-14 day waits in many parts of the country, inhibiting America’s ability to flatten the curve. Now, pharmacists are pushing for the government to slash the red tape that stops them from being providers with the flexibility to test patients for coronavirus.
How AI can speed up clinical trials
AI technology essentially does three things for the clinical trial process: Makes it faster, more reliable and more secure.
Coronavirus testing turnaround times in Florida reveal wide disparity
Health experts say test results that come back after two or three days are nearly worthless, because by then the window for tracing the person’s contacts to prevent additional infections has essentially closed.
Bryan Cranston recovers from coronavirus, donates plasma
Actor Bryan Cranston had mild symptoms including a slight headache, tightness in his chest and loss of taste and smell.



















